As of June 15, 2025, Wattana Karnpaet PCL (NEW.BK) reports a ROE (Return on Equity) of 8.68%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Wattana Karnpaet PCL's ROE (Return on Equity)
Over recent years, Wattana Karnpaet PCL's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-12-31 | 8.68% |
| 2023-12-31 | 11.65% |
| 2022-12-31 | 21.46% |
| 2021-12-31 | 2.37% |
| 2020-12-31 | 0.45% |
This slight downward trend highlights how Wattana Karnpaet PCL manages its efficiency in generating profits from shareholders' equity over time.
Comparing Wattana Karnpaet PCL's ROE (Return on Equity) to Peers
To better understand Wattana Karnpaet PCL's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Wattana Karnpaet PCL (NEW.BK) | 8.68% |
| Chennai Meenakshi Multispeciality Hospital Ltd (523489.BO) | 130.50% |
| Bumrungrad Hospital PCL (BH.BK) | 28.28% |
| Rajthanee Hospital PCL (RJH.BK) | 24.23% |
| Wattanapat Hospital Trang PCL (WPH.BK) | 17.68% |
| Thonburi Medical Centre PCL (KDH.BK) | 17.53% |
Compared to its competitors, Wattana Karnpaet PCL's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.